再鼎医药计划发售784万股存托股份,预计融资不超2.3亿美元

财中社
15 Nov 2024

  财中社11月15日电再鼎医药(09688/ZLAB)发布公告,计划发售784万股美国存托股份,代表7843万股相关股份,发售价为每股25.5美元。此次发售预计在2024年11月18日交割,假设期权全部行使,将增加公司普通股约9.06%。若不行使期权,则相关股份占现有已发行普通股约8.30%。

  公告指出,此次发售所得款项预计在2亿美元至2.3亿美元,净额预计在1.88亿美元至2.16亿美元。公司计划将净款项用于一般企业用途,以增强资金流动性并支持业务发展。此外,发售价格较纳斯达克香港交易所的收市价分别折让约4.39%和10.64%。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10